Stockscreener 앱 받기
8.43
1.93%
0.16
시간 외 거래:
8.36
-0.07
-0.83%
Nuvation Bio Inc 주식(NUVB)의 최신 뉴스
Gap Down: How Nuvation Bio Inc stock reacts to oil prices2025 EndofYear Setup & High Conviction Buy Zone Picks - moha.gov.vn
Nuvation Bio Stock Surges Amid Price Target Boost - TipRanks
Nuvation Bio stock price target raised to $18 from $10 at H.C. Wainwright By Investing.com - Investing.com South Africa
Nuvation Bio stock price target raised to $18 from $10 at H.C. Wainwright - Investing.com Nigeria
HC Wainwright & Co. Maintains Nuvation Bio (NUVB) Buy Recommendation - Nasdaq
Nuvation Bio (NUVB): Reassessing Valuation After Safusidenib Data and Taletrectinib China Reimbursement News - Sahm
Nuvation Bio Inc. $NUVB is Omega Fund Management LLC's 4th Largest Position - MarketBeat
Nuvation Bio (NUVB) price target increased by 12.48% to 10.65 - MSN
Nuvation Bio (NYSE: NUVB) partner taletrectinib added to China's 2025 NRDL - Stock Titan
Nuvation Bio (NUVB) Price Target Increased by 12.48% to 10.65 - Nasdaq
Tema Etfs LLC Purchases Shares of 139,648 Nuvation Bio Inc. $NUVB - MarketBeat
Nuvation Bio Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Nuvation Bio (NUVB) bounces back 12% on impressive clinical trial result - MSN
Why Nuvation Bio Inc. Class stock is a strong analyst pickPortfolio Update Report & Verified Momentum Stock Alerts - Newser
Cash per share of Nuvation Bio Inc. – NYSE:NUVB - TradingView
Will Nuvation Bio Inc. Warrants stock profit from AI boom2025 Risk Factors & Technical Buy Zone Confirmations - Newser
Insider Selling: Nuvation Bio (NYSE:NUVB) Insider Sells 150,000 Shares of Stock - MarketBeat
Why millennials buy Nuvation Bio Inc. Warrants stockJuly 2025 Summary & Risk Managed Investment Signals - Newser
Nuvation Bio (NUVB) Bounces Back 12% on Impressive Clinical Trial Result - Insider Monkey
Nuvation Bio (NYSE:NUVB) Stock Price Up 8.9%Still a Buy? - MarketBeat
NUVB SEC FilingsNuvation Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nuvation Bio’s chief medical officer sells $1.17 million in stock By Investing.com - Investing.com South Africa
Nuvation Bio (NYSE:NUVB) Hits New 1-Year HighHere's What Happened - MarketBeat
Nuvation Bio Inc. (NYSE:NUVB) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Will Nuvation Bio Inc. Class stock profit from AI boomJuly 2025 Selloffs & Trade Opportunity Analysis Reports - Newser
10 Stocks Stealing Market Spotlight - Insider Monkey
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology - Investing News Network
Nuvation Bio’s Surge: Buy or Observe? - StocksToTrade
ETFs Investing in Nuvation Bio Inc. Stocks - TradingView
Nuvation Bio’s chief medical officer sells $1.17 million in stock - Investing.com
Nuvation Bio Insider Sold Shares Worth $1,173,255, According to a Recent SEC Filing - marketscreener.com
Nuvation Bio (NUVB) Chief Medical Officer reports 150K share sale and option exercise - Stock Titan
Nuvation Bio stock hits 52-week high at $8.24 - Investing.com
Nuvation Bio stock hits 52-week high at $8.24 By Investing.com - Investing.com Nigeria
NUVB: Iptrozi and Safusidenib show strong clinical and commercial momentum, driving major growth potential - TradingView
NUVB: Iptrozi and Safusidenib drive strong growth, with robust financials and pipeline innovation - TradingView
Nuvation Bio: Phase 2 study results in IDH1-mutant gliomas published - Traders Union
Will Nuvation Bio Inc. Warrants stock benefit from sector leadershipWeekly Loss Report & Real-Time Volume Analysis - Newser
Geode Capital Management LLC Acquires 864,194 Shares of Nuvation Bio Inc. $NUVB - MarketBeat
Will Nuvation Bio Inc. Class stock outperform benchmarks2025 Big Picture & Long-Term Growth Stock Strategies - Newser
Can Nuvation Bio Inc. Class stock surprise markets with earningsPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser
Is Nuvation Bio Inc. stock a safe buy before earningsTreasury Yields & AI Enhanced Market Trend Forecasts - Newser
Officer Liu Files To Sell 150,000 Of Nuvation Bio Inc [NUVB] - TradingView
H.C. Wainwright reiterates Buy rating on Nuvation Bio stock at $10 target By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Buy rating on Nuvation Bio stock at $10 target - Investing.com Canada
HC Wainwright & Co. Reiterates Nuvation Bio (NUVB) Buy Recommendation - Nasdaq
What is Wedbush's Estimate for Nuvation Bio FY2027 Earnings? - MarketBeat
Truist Financial Sticks to Their Buy Rating for Nuvation Bio (NUVB) - The Globe and Mail
Nuvation Bio’s Strategic Dilemma: Navigating Taletrectinib’s Global Commercialization Risks - MSN
Nuvation Bio: A Strong Company Now Fairly Priced - Seeking Alpha
1.08%
0.91%
자본화:
|
볼륨(24시간):